These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 528780)

  • 1. Study of bioassayable somatomedin on renal artery and vein.
    Minuto F; Barreca A; Grimaldi P; Cocco R; Garibotto G; Ferrini S; Giordano G
    J Endocrinol Invest; 1979; 2(3):305-6. PubMed ID: 528780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum somatomedin A in chronic renal failure.
    Takano K; Hall K; Kastrup KW; Hizuka N; Shizume K; Kawai K; Akimoto M; Takuma T; Sugino N
    J Clin Endocrinol Metab; 1979 Mar; 48(3):371-6. PubMed ID: 218989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid effects on somatomedins and somatomedin inhibitors.
    Unterman TG; Phillips LS
    J Clin Endocrinol Metab; 1985 Oct; 61(4):618-26. PubMed ID: 4031007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth impairment with elevated somatomedin levels in children with chronic renal insufficiency.
    Spencer EM; Uthne KO; Arnold WC
    Acta Endocrinol (Copenh); 1979 May; 91(1):36-48. PubMed ID: 377883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function.
    Phillips LS; Kopple JD
    Metabolism; 1981 Nov; 30(11):1091-5. PubMed ID: 7289882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum somatomedin activity measured as sulphation factor in peripheral, hepatic and renal veins of patients with alcoholic cirrhosis.
    Schimpff RM; Lebrec D; Dannadieu M; Repellin AM
    Acta Endocrinol (Copenh); 1978 Aug; 88(4):729-36. PubMed ID: 581114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum somatomedin activity measured as sulphation factor in peripheral, hepatic and renal veins of mongrel dogs: basal levels.
    Schimpff RM; Donnadieu M; Duval M
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):67-72. PubMed ID: 7355666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease.
    Takano K; Hizuka N; Shizume K; Hayashi N; Motoike Y; Obata H
    J Clin Endocrinol Metab; 1977 Oct; 45(4):828-32. PubMed ID: 914986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin and nutrition on serum levels of somatomedin A in the rat.
    Takano K; Hizuka N; Shizume K; Hasumi Y; Kogawa M; Tsushima T
    Endocrinology; 1980 Nov; 107(5):1614-9. PubMed ID: 6448739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in serum receptor-reactive somatomedin in diabetes.
    Baxter RC; Brown AS; Turtle JR
    Horm Metab Res; 1979 Mar; 11(3):216-20. PubMed ID: 221310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatomedin generating activity of the 20,000-dalton variant of human growth hormone.
    Spencer EM; Lewis LJ; Lewis UJ
    Endocrinology; 1981 Oct; 109(4):1301-2. PubMed ID: 7285874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatomedin activity and inorganic sulfate in children undergoing hemodialysis.
    Phillips LS; Pennisi AJ; Belosky DC; Uittenbogaart C; Ettenger RB; Malekzadeh MH; Fine RN
    J Clin Endocrinol Metab; 1978 Jan; 46(1):165-8. PubMed ID: 752019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma somatomedin activity and diabetic retinopathy.
    Ashton IK; Dornan TL; Pocock AE; Turner RC; Bron AJ
    Clin Endocrinol (Oxf); 1983 Jul; 19(1):105-10. PubMed ID: 6616893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition and somatomedin--XII. Fractionation of somatomedins and somatomedin inhibitors in normal and diabetic rats.
    Phillips LS; Bajaj VR; Fusco AC; Keery KM; Goldstein S
    Int J Biochem; 1985; 17(5):597-603. PubMed ID: 4029480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum somatomedin-C and bioassayable growth-promoting activity (thymidine activity) in appropriate and small-for-gestational-age human newborns.
    Thiériot-Prévost G; Daffos F; Forestier F
    Acta Endocrinol (Copenh); 1985 Sep; 110(1):32-5. PubMed ID: 4041110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin.
    Lanes R; Plotnick LP; Spencer EM; Daughaday WH; Kowarski AA
    J Clin Endocrinol Metab; 1980 Mar; 50(3):485-8. PubMed ID: 6987254
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
    Chochinov RH; Mariz IK; Daughaday WH
    Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 20,000-dalton variant of human growth hormone: effect on bioassayable somatomedin activity in serum.
    Mosier HD; Lewis UJ
    Horm Metab Res; 1982 Aug; 14(8):440-1. PubMed ID: 7129355
    [No Abstract]   [Full Text] [Related]  

  • 20. Depressed serum somatomedin activity in beta-thalassemia.
    Saenger P; Schwartz E; Markenson AL; Graziano JH; Levine LS; New MI; Hilgartner MW
    J Pediatr; 1980 Feb; 96(2):214-8. PubMed ID: 7351582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.